Eletriptan Hydrobromide



Eletriptan Hydrobromide





(ell ah trip’ tan)

Relpax

PREGNANCY CATEGORY C


Drug Classes

Antimigraine drug

5-HT receptor selective agonist

Triptan


Therapeutic Actions

Binds to serotonin receptors to cause vascular constrictive effects on cranial blood vessels, causing the relief of migraine in selective patients.


Indications



  • Treatment of acute migraines with or without aura in adults



Available Forms

Tablets—20, 40 mg


Dosages

Adults

Individualize dosage; 20–40 mg PO. If the headache improves but then returns, a second dose may be given after waiting at least 2 hr. Maximum daily dose, 80 mg.

Pediatric patients

Safety and efficacy not established.


Pharmacokinetics















Route Onset Peak
Oral Rapid 1.5–2 hr

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 20, 2016 | Posted by in NURSING | Comments Off on Eletriptan Hydrobromide

Full access? Get Clinical Tree

Get Clinical Tree app for offline access